Advances in Antibody-Based Immunotherapy in Multiple Myeloma

Time: 9:30 am
day: Day One

Details:

  • Myeloma is still not curable
  • Novel immunotherapies will improve patient outcome
  • Off-the-shelf bispecific antibodies are ideally suited for wide spread clinical applications

Speakers: